1769. The Impact of Checkpoint Inhibitor Immunotherapy on Infections in Lung Cancer Patients

BACKGROUND: Immune checkpoint inhibitors (ICI) therapy has ushered cancer treatment into a potentially curative era. However, infectious complications remain largely unknown and the few studies that described infectious complications associated with ICI had no comparative control groups. We assessed...

Descripción completa

Detalles Bibliográficos
Autores principales: Malek, Alexandre, Fares, Johny, Khalil, Melissa, Hachem, Ray Y, Chaftari, Anne-Marie, Jiang, Ying, Kontoyiannis, Dimitrios P, Fossella, Frank, Chaftari, Patrick, Mulanovich, Victor E, Viola, George, Raad, Issam I
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6809399/
http://dx.doi.org/10.1093/ofid/ofz360.1632

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6809399/
http://dx.doi.org/10.1093/ofid/ofz360.1632

Ejemplares similares